
We don’t stop at GLP-1s.
We also provide NAD+, BPC-157, and a full range of healthy peptides to support your energy, recovery, and overall wellness.
➡️ Your health, your balance, your journey.


GLP-1 medication that regulates appetite, boosts metabolism, and supports healthy, consistent fat loss.

Dual-acting GLP-1 and GIP receptor agonist proven to deliver even greater weight loss results than Semaglutide.

Consult with licensed medical providers from the comfort of your home. Same-day appointments available.

When you choose Annie as your concierge, you’re not just hiring someone with knowledge — you’re gaining a partner who’s lived the journey herself.
Annie lost 40 pounds through this very program, but what transformed her life went far beyond the scale — better sleep, more energy, reduced anxiety, and renewed confidence. That experience drove her to create Healthy Balance Weight Loss, building a dedicated team who share her passion and personal success stories.
With Annie by your side, you get more than guidance — you get a concierge who understands your challenges, celebrates your wins, and makes sure you feel supported every step of the way.
This isn’t just weight loss. This is Annie helping you unlock your best, healthiest self.




Secure intake forms & telehealth with provider
Get custom prescription
Begin GLP-1 treatment
Follow GLP-1 nutrition and hydration plan
Incorporate light movement & strength training
Weekly support, coaching, and check-ins
Transition to long-term maintenance
FAQS
Semaglutide and Tirzepatide are injectable medications that aid in weight loss and blood sugar control. Semaglutide mimics the GLP-1 hormone,which increases insulin secretion and reduces appetite. Tirzepatide combines GLP-1 and GIP receptor agonists, enhancing insulin release and promoting satiety.
Both medications are effective for weight loss. Studies have shown that Tirzepatide may lead to greater weight reduction compared to Semaglutide. For instance, participants using Tirzepatide experienced more significant weight loss than those on Semaglutide.
Common side effects for both medications include nausea, vomiting, diarrhea, constipation, and decreased appetite. These symptoms are often temporary and tend to diminish as the body adjusts to the treatment.
Both Semaglutide and Tirzepatide are administered as subcutaneous injections once a week. The dosage typically starts low and is gradually increased based on individual response and tolerance.
While there's no mandatory diet, adopting a balanced, calorie-controlled diet can enhance the effectiveness of these medications. Focusing on whole foods, lean proteins, and vegetables while limiting processed foods and sugars is beneficial.
It's essential to consult with your healthcare provider before discontinuing the medication. Stopping abruptly may lead to weight regain. A maintenance plan should be discussed to sustain weight loss achievements.
These medications are generally safe for adults with a BMI of 30 or higher, or 27 with weight-related conditions. However, they are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Weight loss results can vary, but many individuals begin to notice changes within a few weeks. Significant weight loss is typically observed over several months of consistent use, combined with lifestyle modifications.
Moderate alcohol consumption may be permissible, but it's advisable to limit intake. Alcohol can exacerbate gastrointestinal side effects and may interfere with blood sugar control. Always consult your healthcare provider regarding alcohol use.
Yes, both medications have shown additional health benefits. Semaglutide has been associated with cardiovascular benefits, while Tirzepatide has demonstrated improvements in metabolic parameters. Ongoing research continues to explore their full range of benefits
